» Articles » PMID: 20824173

Multi-country Evaluation of the Sensitivity and Specificity of Two Commercially-available NS1 ELISA Assays for Dengue Diagnosis

Abstract

Background: Early diagnosis of dengue can assist patient triage and management and prevent unnecessary treatments and interventions. Commercially available assays that detect the dengue virus protein NS1 in the plasma/serum of patients offers the possibility of early and rapid diagnosis.

Methodology/principal Findings: The sensitivity and specificity of the Pan-E Dengue Early ELISA and the Platelia Dengue NS1 Ag assays were compared against a reference diagnosis in 1385 patients in 6 countries in Asia and the Americas. Platelia was more sensitive (66%) than Pan-E (52%) in confirmed dengue cases. Sensitivity varied by geographic region, with both assays generally being more sensitive in patients from SE Asia than the Americas. Both kits were more sensitive for specimens collected within the first few days of illness onset relative to later time points. Pan-E and Platelia were both 100% specific in febrile patients without evidence of acute dengue. In patients with other confirmed diagnoses and healthy blood donors, Platelia was more specific (100%) than Pan-E (90%). For Platelia, when either the NS1 test or the IgM test on the acute sample was positive, the sensitivity versus the reference result was 82% in samples collected in the first four days of fever. NS1 sensitivity was not associated to disease severity (DF or DHF) in the Platelia test, whereas a trend for higher sensitivity in DHF cases was seen in the Pan-E test (however combined with lower overall sensitivity).

Conclusions/significance: Collectively, this multi-country study suggests that the best performing NS1 assay (Platelia) had moderate sensitivity (median 64%, range 34-76%) and high specificity (100%) for the diagnosis of dengue. The poor sensitivity of the evaluated assays in some geographical regions suggests further assessments are needed. The combination of NS1 and IgM detection in samples collected in the first few days of fever increased the overall dengue diagnostic sensitivity.

Citing Articles

Utility of VIDAS Dengue Diagnostic Assays to Differentiate Primary and Secondary Dengue Infection: A Cross-Sectional Study in a Military Hospital from Colombia.

Prieto-Torres A, Medina-Lozano L, Ramirez-Avila J, Faccini-Martinez A Trop Med Infect Dis. 2025; 10(2).

PMID: 39998044 PMC: 11860576. DOI: 10.3390/tropicalmed10020040.


Linking multiple serological assays to infer dengue virus infections from paired samples using mixture models.

Hamins-Puertolas M, Buddhari D, Salje H, Huang A, Hunsawong T, Cummings D medRxiv. 2024; .

PMID: 39711706 PMC: 11661395. DOI: 10.1101/2024.12.08.24318683.


Advanced Detection Method for Dengue NS1 Protein Using Ultrasensitive ELISA with Thio-NAD Cycling.

Chen P, Chang J, Ke L, Kao J, Chen C, Yang R Viruses. 2023; 15(9).

PMID: 37766300 PMC: 10534902. DOI: 10.3390/v15091894.


Early diagnosis of dengue: Diagnostic utility of the SD BIOLINE Dengue Duo rapid test in Reunion Island.

Maillard O, Belot J, Adenis T, Rollot O, Adenis A, Guihard B PLoS Negl Trop Dis. 2023; 17(3):e0011253.

PMID: 36996260 PMC: 10089357. DOI: 10.1371/journal.pntd.0011253.


The Role of NS1 Protein in the Diagnosis of Flavivirus Infections.

Fisher R, Lustig Y, Sklan E, Schwartz E Viruses. 2023; 15(2).

PMID: 36851784 PMC: 9963814. DOI: 10.3390/v15020572.


References
1.
Dussart P, Petit L, Labeau B, Bremand L, Leduc A, Moua D . Evaluation of two new commercial tests for the diagnosis of acute dengue virus infection using NS1 antigen detection in human serum. PLoS Negl Trop Dis. 2008; 2(8):e280. PMC: 2500180. DOI: 10.1371/journal.pntd.0000280. View

2.
Lanciotti R, Calisher C, Gubler D, Chang G, Vorndam A . Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol. 1992; 30(3):545-51. PMC: 265106. DOI: 10.1128/jcm.30.3.545-551.1992. View

3.
Bessoff K, Delorey M, Sun W, Hunsperger E . Comparison of two commercially available dengue virus (DENV) NS1 capture enzyme-linked immunosorbent assays using a single clinical sample for diagnosis of acute DENV infection. Clin Vaccine Immunol. 2008; 15(10):1513-8. PMC: 2565928. DOI: 10.1128/CVI.00140-08. View

4.
Burke D, Nisalak A, Ussery M . Antibody capture immunoassay detection of japanese encephalitis virus immunoglobulin m and g antibodies in cerebrospinal fluid. J Clin Microbiol. 1982; 16(6):1034-42. PMC: 272535. DOI: 10.1128/jcm.16.6.1034-1042.1982. View

5.
Vazquez S, Perez A, Ruiz D, Rodriguez R, Pupo M, Calzada N . Serological markers during dengue 3 primary and secondary infections. J Clin Virol. 2005; 33(2):132-7. DOI: 10.1016/j.jcv.2004.10.013. View